Full Record Display for the EPA National Library Catalog

RECORD NUMBER: 3 OF 8

Main Title Development document for proposed effluent limitations guidelines, new source performance standards and pretreatment standards for the pharmaceutical manufacturing point source category.
CORP Author Environmental Protection Agency, Washington, DC. Effluent Guidelines Div.
Publisher U.S. Environmental Protection Agency, Office of Water, Effluent Guidelines Division,
Year Published 1982
Report Number EPA-440/1-82-084
Stock Number PB94-120110
OCLC Number 09320819
Subjects Drug factories--Waste disposal--Standards--United States ; Drug factories--Environmental aspects--United States ; Effluent quality ; Water use--Standards ; Drug factories--United States--Waste disposal--Standards
Additional Subjects Drug industry ; Industrial waste treatment ; Chemical effluents ; Pollution regulations ; Water pollution control ; Water pollution abatement ; Waste water ; Point sources ; Industrial plants ; Water pollution sampling ; Water pollution economics ; Economic impact ; Pretreatment ; Treatment technology ; BAT(Best available technology)
Internet Access
Description Access URL
https://nepis.epa.gov/Exe/ZyPDF.cgi?Dockey=000011MB.PDF
Holdings
Library Call Number Additional Info Location Last
Modified
Checkout
Status
EJBD  EPA 440/1-82-084 Headquarters Library/Washington,DC 12/29/2006
ELBD ARCHIVE EPA 440/1-82-084 Received from HQ AWBERC Library/Cincinnati,OH 10/04/2023
ELBD  EPA 440-1-82-084 AWBERC Library/Cincinnati,OH 07/30/1999
ESAD  EPA 440-1-82-084 Region 10 Library/Seattle,WA 11/08/2017
NTIS  PB94-120110 Some EPA libraries have a fiche copy filed under the call number shown. 07/26/2022
Collation 1 volume (various pagings) : illustrations ; 28 cm
Abstract The document presents the technical data to support effluent limitations for the pharmaceutical manufacturing point source category as required by the Clean Water Act (The Act) and related settlement agreements. It also presents the technologies to achieve limitations as defined by an amended best practicable control technology currently available (BPT), best available technology economically achievable (BAT) and best conventional pollutant control technology (BCT), and standards as defined by new source performance standards (NSPS), and pretreatment standards for new and existing sources (PSNS and PSES). The pharmaceutical manufacturing point source category manufacture biological products, medicinal chemicals, botanical products and pharmaceutical products.
Notes Cover title: Development document for effluent limitations guidelines and standards to the pharmaceutical point source category. "November 1982." Includes bibliographical references. Includes glossary.
Place Published Washington, D.C.
Supplementary Notes See also PB93-206969 and PB93-208221.
Access Notes Also available on the Internet. Viewed: 12/28/2006.
Corporate Au Added Ent United States. Environmental Protection Agency. Effluent Guidelines Division.
Alternate Title Pharmaceutical manufacturing point source category
PUB Date Free Form 1982
Ti Tra Differently Pharmaceutical manufacturing point source category.
NTIS Prices PC A22/MF A04
BIB Level m
Medium unmediated
Content text
Carrier volume
Cataloging Source OCLC/T
OCLC Time Stamp 20171031052311
Language eng
SUDOCS Number EP 1.8/3:P 49/3/proposed; EP 1.8/3:P 49/3/PROPOSED
Origin OCLC
Type MERGE
OCLC Rec Leader 01849cam 2200445Ia 45010